RxDoctor Payments Data

Kristie McDowell, PA

Medical · King George, VANPI 1275574279

Payments from drug & device makers

$4,230in general payments, 2019–2025

Across 259 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$695
  • Novo Nordisk$507
  • Otsuka America Pharmaceutical, Inc.$404
  • Lilly USA, LLC$378
  • AstraZeneca$253
  • Pfizer$205
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$4,230100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,230 in reported general payments places this provider in the 85th percentile of 632 medical providers in Virginia.

See all medical providers in Virginia

Medicare billing

Part B allowed, 2024
$46,646
Medicare patients
182
Services billed
746

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol30$24,150
JanuviaSitagliptin Phosphate14$17,937
OzempicSemaglutide11$16,970
Levothyroxine Sodium99$1,945
Atorvastatin Calcium107$928
Telmisartan11$515
Rosuvastatin Calcium41$514
Montelukast Sodium32$486
Levocetirizine Dihydrochloride37$443
Amlodipine Besylate68$376
Valsartan21$351
Gabapentin37$333
Omeprazole19$323
Bupropion XlBupropion Hcl19$296
Losartan Potassium26$289

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$253$24,15030 claims
MerckJanuvia$19$17,93714 claims
Novo NordiskOzempic$507$16,97011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 632 medical providers in Virginia.

Other medical in King George

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →